Trexquant Investment LP

Position in ANIK — Anika Therapeutics, Inc.

CIK 1633445 STAMFORD, CT

Position in ANIK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$451,891

-$476,877 QoQ

Shares Held

30,888

-51.8% QoQ

Ownership

0.231%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#50

of 134 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Jun 30, 2026

Trexquant Investment LP holds $109,740,543 across 18 Drug Manufacturers - Specialty & Generic names. ANIK ranks #16 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	676,544	$48,616,451
2	LQDA	Liquidia Corp	110,628	$8,820,370
3	HIMS	Hims & Hers Health, Inc.	233,191	$8,084,731
4	ELAN	Elanco Animal Health Inc	310,453	$7,640,248
5	AMLX	Amylyx Pharmaceuticals, Inc.	349,439	$6,275,924
6	PRGO	PERRIGO Co plc	542,952	$5,641,271
7	ANIP	Ani Pharmaceuticals Inc	56,093	$4,643,378
8	EBS	Emergent BioSolutions Inc.	447,858	$3,753,050

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$451,891	30,888	-51.8%	Shares	Sole	2026-08-14
2026-03-31	$928,768	64,053	-40.3%	Shares	Sole	2026-05-15
2025-12-31	$1,031,220	107,307	+140.1%	Shares	Sole	2026-02-17
2025-09-30	$420,095	44,691	+149.7%	Shares	Sole	2025-11-14
2024-06-30	$453,381	17,899	-51.4%	Shares	Sole	2024-08-13
2024-03-31	$934,745	36,801	-37.1%	Shares	Sole	2024-05-14
2023-12-31	$1,324,771	58,463	+15.4%	Shares	Sole	2024-02-09
2023-09-30	$943,646	50,652	+89.9%	Shares	Sole	2023-11-13
2022-12-31	$789,639	26,677	+75.6%	Shares	Sole	2023-02-13
2022-09-30	$361,569	15,192	-28.2%	Shares	Sole	2022-11-14
2022-06-30	$472,246	21,158	+35.5%	Shares	Sole	2022-08-11
2022-03-31	$391,967	15,610	+211.8%	Shares	Sole	2022-05-13
2021-06-30	$216,709	5,006	—	Shares	Sole	2021-08-12
No filing history on record for this holder in this stock.